HEADER OXIDOREDUCTASE 30-JAN-09 3G1R TITLE CRYSTAL STRUCTURE OF HUMAN LIVER 5BETA-REDUCTASE (AKR1D1) IN COMPLEX TITLE 2 WITH NADP AND FINASTERIDE. RESOLUTION 1.70 A COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3-OXO-5-BETA-STEROID 4-DEHYDROGENASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DELTA(4)-3-KETOSTEROID 5-BETA-REDUCTASE, DELTA(4)-3- COMPND 5 OXOSTEROID 5-BETA-REDUCTASE, ALDO-KETO REDUCTASE FAMILY 1 MEMBER D1; COMPND 6 EC: 1.3.1.3; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKR1D1, SRD5B1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS FINASTERIDE COMPLEX, BILE ACID CATABOLISM, CYTOPLASM, DISEASE KEYWDS 2 MUTATION, INTRAHEPATIC CHOLESTASIS, LIPID METABOLISM, NADP, KEYWDS 3 OXIDOREDUCTASE, STEROID METABOLISM EXPDTA X-RAY DIFFRACTION AUTHOR L.DI COSTANZO,J.E.DRURY,T.M.PENNING,D.W.CHRISTIANSON REVDAT 4 06-SEP-23 3G1R 1 REMARK SEQADV REVDAT 3 24-JUL-19 3G1R 1 REMARK REVDAT 2 05-JAN-10 3G1R 1 JRNL REVDAT 1 09-JUN-09 3G1R 0 JRNL AUTH J.E.DRURY,L.DI COSTANZO,T.M.PENNING,D.W.CHRISTIANSON JRNL TITL INHIBITION OF HUMAN STEROID 5BETA-REDUCTASE (AKR1D1) BY JRNL TITL 2 FINASTERIDE AND STRUCTURE OF THE ENZYME-INHIBITOR COMPLEX. JRNL REF J.BIOL.CHEM. V. 284 19786 2009 JRNL REFN ISSN 0021-9258 JRNL PMID 19515843 JRNL DOI 10.1074/JBC.C109.016931 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.34 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.100 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.5 REMARK 3 NUMBER OF REFLECTIONS : 73560 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 3717 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 24.3400 - 5.0880 0.99 2979 156 0.1500 0.1810 REMARK 3 2 5.0880 - 4.0450 1.00 2844 145 0.1380 0.1420 REMARK 3 3 4.0450 - 3.5350 1.00 2799 150 0.1530 0.1650 REMARK 3 4 3.5350 - 3.2130 1.00 2826 140 0.1750 0.1880 REMARK 3 5 3.2130 - 2.9830 0.99 2761 149 0.1790 0.2070 REMARK 3 6 2.9830 - 2.8070 0.98 2685 179 0.1800 0.2010 REMARK 3 7 2.8070 - 2.6670 0.98 2748 135 0.1840 0.1960 REMARK 3 8 2.6670 - 2.5510 0.98 2687 163 0.1800 0.2250 REMARK 3 9 2.5510 - 2.4530 0.98 2702 150 0.1760 0.2330 REMARK 3 10 2.4530 - 2.3680 0.97 2670 146 0.1710 0.2030 REMARK 3 11 2.3680 - 2.2940 0.97 2684 135 0.1800 0.2020 REMARK 3 12 2.2940 - 2.2290 0.96 2652 153 0.1810 0.2390 REMARK 3 13 2.2290 - 2.1700 0.97 2649 137 0.1720 0.1970 REMARK 3 14 2.1700 - 2.1170 0.96 2657 160 0.1750 0.2290 REMARK 3 15 2.1170 - 2.0690 0.96 2646 132 0.1760 0.2350 REMARK 3 16 2.0690 - 2.0250 0.96 2670 128 0.1830 0.2200 REMARK 3 17 2.0250 - 1.9850 0.94 2567 139 0.1810 0.1990 REMARK 3 18 1.9850 - 1.9470 0.93 2527 142 0.1810 0.2150 REMARK 3 19 1.9470 - 1.9120 0.91 2518 117 0.1790 0.1910 REMARK 3 20 1.9120 - 1.8800 0.90 2468 142 0.1830 0.2430 REMARK 3 21 1.8800 - 1.8500 0.87 2363 122 0.1920 0.2260 REMARK 3 22 1.8500 - 1.8210 0.86 2370 115 0.1930 0.2440 REMARK 3 23 1.8210 - 1.7940 0.86 2362 129 0.1880 0.2340 REMARK 3 24 1.7940 - 1.7690 0.84 2273 116 0.1870 0.2210 REMARK 3 25 1.7690 - 1.7450 0.84 2312 125 0.1900 0.2250 REMARK 3 26 1.7450 - 1.7230 0.83 2251 102 0.1940 0.2420 REMARK 3 27 1.7230 - 1.7010 0.78 2173 110 0.1900 0.2300 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.33 REMARK 3 B_SOL : 31.45 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.220 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.49 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.38 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.77700 REMARK 3 B22 (A**2) : -0.49300 REMARK 3 B33 (A**2) : -0.28500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 5527 REMARK 3 ANGLE : 0.992 7524 REMARK 3 CHIRALITY : 0.067 796 REMARK 3 PLANARITY : 0.006 955 REMARK 3 DIHEDRAL : 16.950 2212 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE BINDING STEROID POCKET OF MONOMER A REMARK 3 SHOWED A DISCONTINUOUS PEAK THAT WAS NOT POSSIBLE TO FIT WITH REMARK 3 FINASTERIDE MOLECULE OR A DIFFERENT LIGAND. REMARK 4 REMARK 4 3G1R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-FEB-09. REMARK 100 THE DEPOSITION ID IS D_1000051313. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JUN-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X6A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 76941 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.04900 REMARK 200 R SYM (I) : 0.04900 REMARK 200 FOR THE DATA SET : 25.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : 0.35000 REMARK 200 R SYM FOR SHELL (I) : 0.35000 REMARK 200 FOR SHELL : 3.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 3CMF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.88 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THE TERNARY COMPLEXES OF AKR1D1-NADP+ REMARK 280 -FINASTERIDE WAS CRYSTALLIZED BY THE HANGING DROP VAPOR REMARK 280 DIFFUSION METHOD AT 4 C. DROPS CONTAINING 3.0 L OF ENZYME REMARK 280 SOLUTION [5.0 MG/ML AKR1D1, 2.0 MM NADP+, 0.5 MM FINASTERIDE, REMARK 280 10.0 MM TRIS (PH 7.4)] AND 4.0 L OF PRECIPITANT BUFFER [0.1 M REMARK 280 TRIS-HCL (PH 7.0), 10-20% (WT/VOL) PEG 4000, 10% ISO-PROPANOL] REMARK 280 WERE EQUILIBRATED AGAINST A 1 ML RESERVOIR OF PRECIPITANT REMARK 280 BUFFER. CRYSTALS OF THE AKR1D1-NADP+-FINASTERIDE, COMPLEX WERE REMARK 280 SOAKED FOR 24 HOURS IN THE SAME MOTHER LIQUOR SOLUTION AUGMENTED REMARK 280 WITH 2.0 MM NADP+, 2.0 MM FINASTERIDE AND 30% ISO-PROPANOL, REMARK 280 VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.94600 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.48050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 54.93850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 64.48050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.94600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 54.93850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -19 REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PRO A -4 REMARK 465 ARG A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 MET B -19 REMARK 465 GLY B -18 REMARK 465 SER B -17 REMARK 465 SER B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 SER B -9 REMARK 465 SER B -8 REMARK 465 GLY B -7 REMARK 465 LEU B -6 REMARK 465 VAL B -5 REMARK 465 PRO B -4 REMARK 465 ARG B -3 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 8 34.21 -145.21 REMARK 500 SER A 220 49.94 39.64 REMARK 500 THR A 224 170.27 73.69 REMARK 500 TRP A 230 -9.55 -140.69 REMARK 500 HIS B 8 37.02 -144.54 REMARK 500 ALA B 55 143.19 -170.12 REMARK 500 THR B 224 168.72 78.74 REMARK 500 TRP B 230 -16.57 -149.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 944 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP B 943 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FIT B 327 DBREF 3G1R A 1 326 UNP P51857 AK1D1_HUMAN 1 326 DBREF 3G1R B 1 326 UNP P51857 AK1D1_HUMAN 1 326 SEQADV 3G1R MET A -19 UNP P51857 EXPRESSION TAG SEQADV 3G1R GLY A -18 UNP P51857 EXPRESSION TAG SEQADV 3G1R SER A -17 UNP P51857 EXPRESSION TAG SEQADV 3G1R SER A -16 UNP P51857 EXPRESSION TAG SEQADV 3G1R HIS A -15 UNP P51857 EXPRESSION TAG SEQADV 3G1R HIS A -14 UNP P51857 EXPRESSION TAG SEQADV 3G1R HIS A -13 UNP P51857 EXPRESSION TAG SEQADV 3G1R HIS A -12 UNP P51857 EXPRESSION TAG SEQADV 3G1R HIS A -11 UNP P51857 EXPRESSION TAG SEQADV 3G1R HIS A -10 UNP P51857 EXPRESSION TAG SEQADV 3G1R SER A -9 UNP P51857 EXPRESSION TAG SEQADV 3G1R SER A -8 UNP P51857 EXPRESSION TAG SEQADV 3G1R GLY A -7 UNP P51857 EXPRESSION TAG SEQADV 3G1R LEU A -6 UNP P51857 EXPRESSION TAG SEQADV 3G1R VAL A -5 UNP P51857 EXPRESSION TAG SEQADV 3G1R PRO A -4 UNP P51857 EXPRESSION TAG SEQADV 3G1R ARG A -3 UNP P51857 EXPRESSION TAG SEQADV 3G1R GLY A -2 UNP P51857 EXPRESSION TAG SEQADV 3G1R SER A -1 UNP P51857 EXPRESSION TAG SEQADV 3G1R HIS A 0 UNP P51857 EXPRESSION TAG SEQADV 3G1R MET B -19 UNP P51857 EXPRESSION TAG SEQADV 3G1R GLY B -18 UNP P51857 EXPRESSION TAG SEQADV 3G1R SER B -17 UNP P51857 EXPRESSION TAG SEQADV 3G1R SER B -16 UNP P51857 EXPRESSION TAG SEQADV 3G1R HIS B -15 UNP P51857 EXPRESSION TAG SEQADV 3G1R HIS B -14 UNP P51857 EXPRESSION TAG SEQADV 3G1R HIS B -13 UNP P51857 EXPRESSION TAG SEQADV 3G1R HIS B -12 UNP P51857 EXPRESSION TAG SEQADV 3G1R HIS B -11 UNP P51857 EXPRESSION TAG SEQADV 3G1R HIS B -10 UNP P51857 EXPRESSION TAG SEQADV 3G1R SER B -9 UNP P51857 EXPRESSION TAG SEQADV 3G1R SER B -8 UNP P51857 EXPRESSION TAG SEQADV 3G1R GLY B -7 UNP P51857 EXPRESSION TAG SEQADV 3G1R LEU B -6 UNP P51857 EXPRESSION TAG SEQADV 3G1R VAL B -5 UNP P51857 EXPRESSION TAG SEQADV 3G1R PRO B -4 UNP P51857 EXPRESSION TAG SEQADV 3G1R ARG B -3 UNP P51857 EXPRESSION TAG SEQADV 3G1R GLY B -2 UNP P51857 EXPRESSION TAG SEQADV 3G1R SER B -1 UNP P51857 EXPRESSION TAG SEQADV 3G1R HIS B 0 UNP P51857 EXPRESSION TAG SEQRES 1 A 346 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 346 LEU VAL PRO ARG GLY SER HIS MET ASP LEU SER ALA ALA SEQRES 3 A 346 SER HIS ARG ILE PRO LEU SER ASP GLY ASN SER ILE PRO SEQRES 4 A 346 ILE ILE GLY LEU GLY THR TYR SER GLU PRO LYS SER THR SEQRES 5 A 346 PRO LYS GLY ALA CYS ALA THR SER VAL LYS VAL ALA ILE SEQRES 6 A 346 ASP THR GLY TYR ARG HIS ILE ASP GLY ALA TYR ILE TYR SEQRES 7 A 346 GLN ASN GLU HIS GLU VAL GLY GLU ALA ILE ARG GLU LYS SEQRES 8 A 346 ILE ALA GLU GLY LYS VAL ARG ARG GLU ASP ILE PHE TYR SEQRES 9 A 346 CYS GLY LYS LEU TRP ALA THR ASN HIS VAL PRO GLU MET SEQRES 10 A 346 VAL ARG PRO THR LEU GLU ARG THR LEU ARG VAL LEU GLN SEQRES 11 A 346 LEU ASP TYR VAL ASP LEU TYR ILE ILE GLU VAL PRO MET SEQRES 12 A 346 ALA PHE LYS PRO GLY ASP GLU ILE TYR PRO ARG ASP GLU SEQRES 13 A 346 ASN GLY LYS TRP LEU TYR HIS LYS SER ASN LEU CYS ALA SEQRES 14 A 346 THR TRP GLU ALA MET GLU ALA CYS LYS ASP ALA GLY LEU SEQRES 15 A 346 VAL LYS SER LEU GLY VAL SER ASN PHE ASN ARG ARG GLN SEQRES 16 A 346 LEU GLU LEU ILE LEU ASN LYS PRO GLY LEU LYS HIS LYS SEQRES 17 A 346 PRO VAL SER ASN GLN VAL GLU CYS HIS PRO TYR PHE THR SEQRES 18 A 346 GLN PRO LYS LEU LEU LYS PHE CYS GLN GLN HIS ASP ILE SEQRES 19 A 346 VAL ILE THR ALA TYR SER PRO LEU GLY THR SER ARG ASN SEQRES 20 A 346 PRO ILE TRP VAL ASN VAL SER SER PRO PRO LEU LEU LYS SEQRES 21 A 346 ASP ALA LEU LEU ASN SER LEU GLY LYS ARG TYR ASN LYS SEQRES 22 A 346 THR ALA ALA GLN ILE VAL LEU ARG PHE ASN ILE GLN ARG SEQRES 23 A 346 GLY VAL VAL VAL ILE PRO LYS SER PHE ASN LEU GLU ARG SEQRES 24 A 346 ILE LYS GLU ASN PHE GLN ILE PHE ASP PHE SER LEU THR SEQRES 25 A 346 GLU GLU GLU MET LYS ASP ILE GLU ALA LEU ASN LYS ASN SEQRES 26 A 346 VAL ARG PHE VAL GLU LEU LEU MET TRP ARG ASP HIS PRO SEQRES 27 A 346 GLU TYR PRO PHE HIS ASP GLU TYR SEQRES 1 B 346 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 346 LEU VAL PRO ARG GLY SER HIS MET ASP LEU SER ALA ALA SEQRES 3 B 346 SER HIS ARG ILE PRO LEU SER ASP GLY ASN SER ILE PRO SEQRES 4 B 346 ILE ILE GLY LEU GLY THR TYR SER GLU PRO LYS SER THR SEQRES 5 B 346 PRO LYS GLY ALA CYS ALA THR SER VAL LYS VAL ALA ILE SEQRES 6 B 346 ASP THR GLY TYR ARG HIS ILE ASP GLY ALA TYR ILE TYR SEQRES 7 B 346 GLN ASN GLU HIS GLU VAL GLY GLU ALA ILE ARG GLU LYS SEQRES 8 B 346 ILE ALA GLU GLY LYS VAL ARG ARG GLU ASP ILE PHE TYR SEQRES 9 B 346 CYS GLY LYS LEU TRP ALA THR ASN HIS VAL PRO GLU MET SEQRES 10 B 346 VAL ARG PRO THR LEU GLU ARG THR LEU ARG VAL LEU GLN SEQRES 11 B 346 LEU ASP TYR VAL ASP LEU TYR ILE ILE GLU VAL PRO MET SEQRES 12 B 346 ALA PHE LYS PRO GLY ASP GLU ILE TYR PRO ARG ASP GLU SEQRES 13 B 346 ASN GLY LYS TRP LEU TYR HIS LYS SER ASN LEU CYS ALA SEQRES 14 B 346 THR TRP GLU ALA MET GLU ALA CYS LYS ASP ALA GLY LEU SEQRES 15 B 346 VAL LYS SER LEU GLY VAL SER ASN PHE ASN ARG ARG GLN SEQRES 16 B 346 LEU GLU LEU ILE LEU ASN LYS PRO GLY LEU LYS HIS LYS SEQRES 17 B 346 PRO VAL SER ASN GLN VAL GLU CYS HIS PRO TYR PHE THR SEQRES 18 B 346 GLN PRO LYS LEU LEU LYS PHE CYS GLN GLN HIS ASP ILE SEQRES 19 B 346 VAL ILE THR ALA TYR SER PRO LEU GLY THR SER ARG ASN SEQRES 20 B 346 PRO ILE TRP VAL ASN VAL SER SER PRO PRO LEU LEU LYS SEQRES 21 B 346 ASP ALA LEU LEU ASN SER LEU GLY LYS ARG TYR ASN LYS SEQRES 22 B 346 THR ALA ALA GLN ILE VAL LEU ARG PHE ASN ILE GLN ARG SEQRES 23 B 346 GLY VAL VAL VAL ILE PRO LYS SER PHE ASN LEU GLU ARG SEQRES 24 B 346 ILE LYS GLU ASN PHE GLN ILE PHE ASP PHE SER LEU THR SEQRES 25 B 346 GLU GLU GLU MET LYS ASP ILE GLU ALA LEU ASN LYS ASN SEQRES 26 B 346 VAL ARG PHE VAL GLU LEU LEU MET TRP ARG ASP HIS PRO SEQRES 27 B 346 GLU TYR PRO PHE HIS ASP GLU TYR HET NAP A 944 48 HET NAP B 943 48 HET FIT B 327 27 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM FIT (4AR,4BS,6AS,7S,9AS,9BS,11AR)-N-TERT-BUTYL-4A,6A- HETNAM 2 FIT DIMETHYL-2-OXO-2,4A,4B,5,6,6A,7,8,9,9A,9B,10,11,11A- HETNAM 3 FIT TETRADECAHYDRO-1H-INDENO[5,4-F]QUINOLINE-7-CARBOXAMIDE HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE HETSYN FIT FINASTERIDE FORMUL 3 NAP 2(C21 H28 N7 O17 P3) FORMUL 5 FIT C23 H36 N2 O2 FORMUL 6 HOH *754(H2 O) HELIX 1 1 GLU A 28 THR A 32 5 5 HELIX 2 2 GLY A 35 GLY A 48 1 14 HELIX 3 3 ALA A 55 GLN A 59 5 5 HELIX 4 4 ASN A 60 GLU A 74 1 15 HELIX 5 5 ARG A 78 ILE A 82 5 5 HELIX 6 6 TRP A 89 HIS A 93 5 5 HELIX 7 7 VAL A 94 GLN A 110 1 17 HELIX 8 8 ASN A 146 ALA A 160 1 15 HELIX 9 9 ASN A 172 ASN A 181 1 10 HELIX 10 10 GLN A 202 HIS A 212 1 11 HELIX 11 11 PRO A 237 LYS A 240 5 4 HELIX 12 12 ASP A 241 ASN A 252 1 12 HELIX 13 13 THR A 254 ARG A 266 1 13 HELIX 14 14 ASN A 276 GLN A 285 1 10 HELIX 15 15 THR A 292 ALA A 301 1 10 HELIX 16 16 LEU A 311 ARG A 315 5 5 HELIX 17 17 GLU B 28 THR B 32 5 5 HELIX 18 18 GLY B 35 GLY B 48 1 14 HELIX 19 19 ALA B 55 GLN B 59 5 5 HELIX 20 20 ASN B 60 GLU B 74 1 15 HELIX 21 21 ARG B 78 ILE B 82 5 5 HELIX 22 22 TRP B 89 HIS B 93 5 5 HELIX 23 23 VAL B 94 GLU B 96 5 3 HELIX 24 24 MET B 97 GLN B 110 1 14 HELIX 25 25 ASN B 146 ALA B 160 1 15 HELIX 26 26 ASN B 172 ASN B 181 1 10 HELIX 27 27 GLN B 202 HIS B 212 1 11 HELIX 28 28 PRO B 237 LYS B 240 5 4 HELIX 29 29 ASP B 241 TYR B 251 1 11 HELIX 30 30 THR B 254 ARG B 266 1 13 HELIX 31 31 ASN B 276 GLN B 285 1 10 HELIX 32 32 THR B 292 ALA B 301 1 10 HELIX 33 33 LEU B 311 ARG B 315 5 5 SHEET 1 A 2 ARG A 9 PRO A 11 0 SHEET 2 A 2 SER A 17 PRO A 19 -1 O ILE A 18 N ILE A 10 SHEET 1 B 8 LEU A 23 GLY A 24 0 SHEET 2 B 8 HIS A 51 ASP A 53 1 O ASP A 53 N LEU A 23 SHEET 3 B 8 PHE A 83 LEU A 88 1 O PHE A 83 N ILE A 52 SHEET 4 B 8 VAL A 114 ILE A 119 1 O ILE A 118 N LEU A 88 SHEET 5 B 8 VAL A 163 SER A 169 1 O GLY A 167 N TYR A 117 SHEET 6 B 8 SER A 191 GLU A 195 1 O SER A 191 N VAL A 168 SHEET 7 B 8 VAL A 215 TYR A 219 1 O TYR A 219 N VAL A 194 SHEET 8 B 8 VAL A 269 VAL A 270 1 O VAL A 269 N ALA A 218 SHEET 1 C 2 ALA A 124 PHE A 125 0 SHEET 2 C 2 TYR A 142 HIS A 143 -1 O HIS A 143 N ALA A 124 SHEET 1 D 2 ARG B 9 PRO B 11 0 SHEET 2 D 2 SER B 17 PRO B 19 -1 O ILE B 18 N ILE B 10 SHEET 1 E 8 LEU B 23 GLY B 24 0 SHEET 2 E 8 HIS B 51 ASP B 53 1 O ASP B 53 N LEU B 23 SHEET 3 E 8 PHE B 83 LEU B 88 1 O PHE B 83 N ILE B 52 SHEET 4 E 8 VAL B 114 ILE B 119 1 O ILE B 118 N LEU B 88 SHEET 5 E 8 VAL B 163 SER B 169 1 O LYS B 164 N VAL B 114 SHEET 6 E 8 SER B 191 GLU B 195 1 O SER B 191 N VAL B 168 SHEET 7 E 8 VAL B 215 TYR B 219 1 O TYR B 219 N VAL B 194 SHEET 8 E 8 VAL B 269 VAL B 270 1 O VAL B 269 N ALA B 218 SITE 1 AC1 33 GLY A 24 THR A 25 TYR A 26 ASP A 53 SITE 2 AC1 33 TYR A 58 SER A 169 ASN A 170 GLN A 193 SITE 3 AC1 33 TYR A 219 SER A 220 PRO A 221 LEU A 222 SITE 4 AC1 33 GLY A 223 THR A 224 SER A 225 LEU A 239 SITE 5 AC1 33 ALA A 256 ILE A 271 PRO A 272 LYS A 273 SITE 6 AC1 33 SER A 274 PHE A 275 ARG A 279 GLU A 282 SITE 7 AC1 33 ASN A 283 HOH A 338 HOH A 394 HOH A 395 SITE 8 AC1 33 HOH A 456 HOH A 519 HOH A 541 HOH A 580 SITE 9 AC1 33 HOH A 738 SITE 1 AC2 37 GLY B 24 THR B 25 TYR B 26 ASP B 53 SITE 2 AC2 37 TYR B 58 SER B 169 ASN B 170 GLN B 193 SITE 3 AC2 37 TYR B 219 SER B 220 PRO B 221 LEU B 222 SITE 4 AC2 37 GLY B 223 THR B 224 SER B 225 LEU B 239 SITE 5 AC2 37 ALA B 256 ILE B 271 PRO B 272 LYS B 273 SITE 6 AC2 37 SER B 274 PHE B 275 ARG B 279 GLU B 282 SITE 7 AC2 37 ASN B 283 FIT B 327 HOH B 387 HOH B 418 SITE 8 AC2 37 HOH B 422 HOH B 426 HOH B 459 HOH B 460 SITE 9 AC2 37 HOH B 529 HOH B 534 HOH B 558 HOH B 598 SITE 10 AC2 37 HOH B 623 SITE 1 AC3 10 TYR B 26 TYR B 58 TRP B 89 GLU B 120 SITE 2 AC3 10 TYR B 132 TRP B 140 TRP B 230 HOH B 460 SITE 3 AC3 10 HOH B 463 NAP B 943 CRYST1 49.892 109.877 128.961 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020043 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009101 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007754 0.00000